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p62dok: A Constitutively Tyrosine-Phosphorylated,
GAP-Associated Protein in Chronic Myelogenous
Leukemia Progenitor Cells
Nick Carpino,*² David Wisniewski,³ the functional breakdown of the hematopoietic system
(Sawyers et al., 1991; Clarkson and Strife, 1993).Annabel Strife,³ Daniel Marshak,*§
Ryuji Kobayashi,* Bruce Stillman,* It has become widely accepted that the cause of CML
is the t(9;22) translocation (Daley and Ben Neriah, 1991).and Bayard Clarkson³
*Cold Spring Harbor Laboratory The gene encoding c-Abl, a tyrosine kinase, lies on the
distal arm of chromosome 9. The translocation placesCold Spring Harbor, New York 11724
²Program in Molecular and Cellular Biology the promoter distal three exons of abl, including those
elements which encode the tyrosine kinase domain,State University of New York
Stony Brook, New York 11794±5215 downstream of either the first or second exon of the
gene bcr, located on chromosome 22 (Chung and Wong,³Memorial Sloan Kettering Cancer Center
1275 York Avenue 1995). The product of this chimeric bcr-abl gene is a
fusion protein known either as p185bcr-abl or p210bcr-abl,New York, New York 10021
depending upon the inclusion of the second exon of
bcr. The p185bcr-abl protein causes acute leukemia, most
commonly lymphoblastic,while p210bcr-abl usually causes
Summary
CML, but can occasionally also cause acute leukemia
(Groffen et al., 1991). Relative to normal c-Abl, Bcr-Abl
Characteristic of chronic myelogenous leukemia
has increased tyrosine kinase activity and can transform(CML) is the presence of the chimeric p210bcr-abl protein
a variety of fibroblastic and hematopoietic cell lines inpossessing elevated protein tyrosine kinase activity
culture (Konopka et al., 1984; Lugo et al., 1990). Addi-relative to normal c-abl tyrosinekinase. Hematopoietic
tionally, while c-Abl, as a nonreceptor tyrosine kinase,progenitors isolated from CML patients in the chronic
functions both in the nucleus and the cytoplasm, Bcr-phase contain a constitutively tyrosine-phosphory-
Abl is exclusively cytoplasmic. Both the elevated kinaselated protein that migrates at 62 kDa by SDS±PAGE
activity and the subcellular localization of the oncoprot-and associates with the p120 ras GTPase-activating
ein areconsidered essential elements of its transformingprotein (GAP). We have purified p62dok from a hemato-
abilities (McWhirter and Wang, 1991).poietic cell line expressing p210bcr-abl. p62dok is a novel
Although identifying the specific and direct biological
protein with features of a signaling molecule. Associa-
consequences of p210bcr-abl activity in hematopoietic
tion of p62dok with GAP correlates with its tyrosine
progenitors has been hampered by the lack of a suitable
phosphorylation. p62dok is rapidly tyrosine-phosphory-
biological system mimicking CML, evidence suggests
lated upon activation of the c-Kit receptor, implicating
that the kinase directly affects signaling pathways
it as a component of a signal transduction pathway
involved in controlling the maturational developmentdownstream of receptor tyrosine kinases.
of primitive hematopoietic progenitors (Clarkson and
Strife, 1993). To understand the molecular mechanism
of p210bcr-abl-mediated transformation, we initiated a se-Introduction
ries of biochemical studies comparing progenitor cells
derived from normal or Ph1 chronic-phase marrows.Chronic myelogenous leukemia (CML) is a form of leu-
kemia with distinct clinical and pathological features Populations of progenitors from total marrow aspirates
were isolated by a combination of density separation(reviewed by Clarkson and Strife, 1993). A well-charac-
terized chromosomal translocation within a single, prim- and negative selection with a panel of monoclonal anti-
bodies (Strife et al., 1993). Then, lysates of primitiveitive myeloid stem cell results in the creation of a minute
chromosome 22 known as the Philadelphia chromo- blasts derived from either normal or Ph1 chronic-phase
marrow in which the only detectable cytogenetic abnor-some (Ph1). Following the translocation, there ensues
a period of several years during which the progeny of mality was the presence of the Philadelphia chromosome
were analyzed by immunoblotting, using anti-phospho-the affected cell gradually populate the entire intermedi-
ate and late hematopoietic maturational compartments. tyrosine antibodies to identify possible differences in
the state of tyrosine phosphorylation among proteinsThe Ph1 progeny are able to differentiate and mature
along the various myeloid lineages. In addition, they in the two populations. A 62 kDa protein (p62) was found
to be constitutively tyrosine-phosphorylated in the latterretain the capacity to function similarly to their normal,
unaffected counterparts. Invariably, over an average population, in all patients studied (Wisniewski et al.,
1994). We have purified p62, cloned the cDNA, and be-span of three to five years, the disease progresses into
a malignant stage known as ªblast crisis.º The affected gun to characterize its function.
cells acquire additional chromosomal abnormalities and
lose their ability to differentiate and mature, resulting in Results
Identification and Purification of p62dok§Present Address: Osiris Therapeutics, 2001 Aliceanna St., Balti-
Following the initial observation of tyrosine-phosphory-more, Maryland 21231±2001 and Department of Oncology, The
lated p62 in primary CML progenitor cells (WisniewskiJohns Hopkins University School of Medicine, Baltimore, Maryland
21205. et al., 1994), we chose to work with the Mo7 cell line
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Figure 1. Identification and Purification of
a Tyrosine-Phosphorylated, GAP-Associated
p62
(A) The indicated antibodies were used in im-
munoprecipitations from lysates of either
Mo7 or Mo7/p210 cells. Immune complexes
were separated by SDS±PAGE and trans-
ferred to nitrocellulose. The blot was probed
with anti-pTyr antibodies. The position of the
p62 doublet is indicated. SC-108 is a com-
mercially available antibody against a p68
protein thought to associate with GAP. (Ig)
indicates immunoglobulin.
(B) Anti-GAP immunoprecipitation from 32P-
labeled cells, analyzed by 2D gel electropho-
resis. The bracket indicates a series of spots
representing p62dok. A similar pattern was ob-
tained by incubating lysates of labeled cells
with glutathione-agarose beads, to which
were bound GST fused to the SH2±SH3±SH2
region of GAP, and analyzing the captured
proteins by 2D gel electrophoresis (middle
panel). Immunoprecipitated p62 comigrated
with p62 bound to GST GAP SH2±SH3±SH2
(lower panel).
(C) Final step in the purification of p62dok.
pTyr-containing proteins that were eluted
from the SP column (see Experimental Pro-
cedures) were captured by an anti-pTyr an-
tibody column and separated by 2D gel
electrophoresis. The gel was stained with
Coomassie Brilliant Blue. p62dok is indicated.
and a derivative of Mo7 expressing p210bcr-abl, Mo7/p210 gel electrophoresis. A characteristic pattern of spots
migrating at 62 kDa resulted, suggestive of different(Avanzi et al.,1988). We examined whether or not the p62
protein was similar to the molecule heretofore known as phosphorylation-state isoforms (Figure 1B, top panel).
Because p62 previously had been shown to bind to thethe GAP-associated p62 by immunoprecipitating GAP
from cytoplasmic lysates of Mo7 cells and cells express- SH2±SH3±SH2 region of GAP (Marengere and Pawson,
1992), we conducted in vitro binding experiments, utiliz-ing p210bcr-abl and analyzing the precipitated complexes
by anti-phosphotyrosine immunoblotting (Figure 1A) (El- ing GST fused in-frame to the GAP SH2±SH3±SH2 re-
gion. These experiments yielded a two-dimensional pat-lis et al., 1990). Anti-GAP immunoprecipitates from Mo7/
p210 lysates, but not from Mo7 lysates, contained tyro- tern of phosphorylated proteins migrating at 62 kDa
identical to that obtained from GAP immunoprecipita-sine-phosphorylated p62 that migrated as a doublet
(Figure 1A, lanes 3 and 4). The GAP-associated doublet tions (Figure 1B, middle and bottom panels). A combina-
tion of conventional and immunoaffinity chromatogra-was also observed in anti-phosphotyrosine immunopre-
cipitates from lysates of Mo7/p210 cells, but not from phy was used to purify p62dok. Lysates of Mo7/p210
cells were passed sequentially over two ion-exchangeMo7 cells (Figure 1A, lanes 5 and 6). However, we were
unable to detect a similar protein in complexes precipi- columns, following which an anti-pTyr antibody column
was used to capture remaining tyrosine-phosphorylatedtated by rabbit polyclonal antibodies against the mole-
cule previously reported as the GAP-associated p62 proteins. As a final step in the purification, proteins
eluted from the antibody column were separated by 2D(Figure 1A, lanes 7 and 8) (Wong et al., 1992; Lock et
al., 1996). The same polyclonal antibodies were unable gel electrophoresis (Figure 1C).
to immunoblot a specific polypeptide in anti-GAP immu-
noprecipitates, nor could they precipitate a phosphory- p62dok Has Features of a Signaling Molecule
Coomassie blue±stained p62dok was excised from a gellated 62 kDa polypeptide from lysates of 32P-labeled
Mo7/p210 cells (data not shown). These immunological and digested with protease to yield peptide fragments,
five of which were sequenced (see Figure 2A). Degener-discrepancies encouraged us to purify the p62 protein,
henceforth called p62dok (p62 protein downstream of ty- ate oligonucleotide primers were designed based on
the amino acid sequence of two peptides and used inrosine kinases).
To purify p62dok, an assay for the identity of the protein RT±PCR to amplify a fragment of p62dok cDNA. After
three rounds of nested PCR, a 900 bp product waswas developed. We precipitated GAP from cytoplasmic
lysates of 32P-labeled cells expressing p210bcr-abl and an- obtained, which we used subsequently to screen a hu-
man teratocarcinoma cDNA library (Skowronski et al.,alyzed the immune complexes by 2D (two-dimensional)
GAP-Associated p62 Protein
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Figure 3. Northern Blot Analysis
Northern blots containing poly(A)1 RNA from multiple human tissues
were probed with a Dok cDNA probe (upper panels) or an actin
probe (lower panels). Positions of the Dok mRNA and actin mRNAs
(2.0 and 1.8 kb) are indicated, as are positions of standard markers.
Recently, the substrate specifities of a variety of tyro-
sine kinases were proposed (Songyang et al., 1995). The
optimal peptide substrate of the c-Abl kinase was found
to be I/V/LYAAP/F. Although none of the tyrosines of
p62dok have adjacent residues exactly matching this con-Figure 2. Structure of p62dok
sensus sequence, residues 295±299 (LYAEP) are a close(A) Predicted amino acid sequence of p62dok. The positions of the
match. Additionally, three tyrosines are within the con-peptides obtained by microsequencing are underlined. The putative
text I/LYXXP. Therefore, p62dok might be a direct sub-PH domain is amino acids 3±119. The peptide used to generate
rabbit polyclonal antibodies is shown in bold. strate of p210bcr-abl. In addition, the recognition specificit-
(B) Schematic diagram of p62dok. The PH domain is indicated. The ies of the SH2 domains of a variety of known signaling
vertical bars indicate the location of the tyrosines within p62dok. In molecules have been proposed (Songyang et al., 1994).
addition, the locations of the PXXP motifs are indicated by (P).
One of the p62dok tyrosines (residue 449) is in a context
that is consistent with the proposed SH2 recognition
motifs. This most C-terminal tyrosine is located within1988). A screen of 750,000 individual phage clones
the sequence SALYSQVQ, suggesting that this site, ifyielded five positives. The amino acid sequence en-
phosphorylated, might associate with the SH2 domaincoded by the longest insert representing Dok cDNA is
of Csk, the C-terminal Src kinase. Evidence for the directillustrated in Figure 2A. The cDNA encoded a novel pro-
interaction between the SH2 domain of Csk and thetein of 481 amino acids with a predicted molecular mass
GAP-associated p62 has been presented (Neet andof 53 kDa. Northern blot analysis indicated a Dok mes-
Hunter, 1995). It is possible that, in addition to GAP,sage of approximately 1.9±2.0 kb (see Figure 3). In vitro±
tyrosine-phosphorylated p62dok forms a complex withtranslated p62dok migrated at 61 kDa by SDS±PAGE,
Csk and other yet unknown SH2 domain±containing sig-similar to p62dok immunoprecipitated from Mo7 cells by
naling proteins.anti-p62dok antibodies (data not shown). A profile search
To demonstrate that the clone we isolated encoded autilizing the Prosite profile database detected a putative
GAP-associated p62, rabbit polyclonal antibodies werepleckstrin homology (PH) domain (Musacchio et al.,
raised against a synthetic peptide derived from the se-1993) at the extreme N terminus of p62dok (see Figure 2B).
quence of p62dok. Figure 4 illustrates that the antibodiesAside from this, we were unable to find any significant
immunoprecipitated a tyrosine-phosphorylated 62 kDahomology between p62dok and other known proteins.
doublet from Mo7/p210 lysates (Figure 4A, lane 1). Thep62dok has 15 tyrosines, 10 of which are located within
antigenic peptide specifically blocked the ability of thea C-terminal stretch one-third of the length of the mole-
antibody to precipitate this doublet (Figure 4A, lane 2),cule. Kyte-Doolittle hydrophobicity analysis indicates
while an unrelated peptide had no effect (Figure 4A, lanethat this region of p62dok is more hydrophilic than other
3). Furthermore, anti-p62dok antibodies detected a 62portions of the molecule. Additionally, p62dok is relatively
kDa doublet in immunoblots of proteins that coimmuno-proline-rich, with ten PXXP motifs (see Figure 2B). The
precipitated with antibodies directed against GAP (Fig-PXXP motif has been demonstrated to be the most con-
ure 4B, lane 1), and the antigenic peptide specificallyserved motif within known SH3 domain ligands (Yu et
blocked the ability of the antibody to detect this doublet,al., 1994), suggesting that p62dok might form signaling
while an unrelated peptide had no effect (Figure 4B,complexes with other molecules that contain SH3
domains. lanes 2 and 3). Taken together, these data demonstrated
Cell
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We then investigated whether p62dok was involved in
a signal transduction pathway initiated by a receptor
tyrosine kinase. Previous studies had implicated a 62
kDa protein as a downstream target of c-Kit receptor
kinase activity in human primary-lineage negative-nor-
mal hematopoietic progenitor cells (Wisniewski et al.,
1996). The c-Kit receptor is a type II receptor tyrosine
kinase that is structurally related to the PDGF receptor
(van der Geer et al., 1993). Its ligand, c-Kit ligand, has
pleitropic effects on the development of diverse cell
types (Galli et al., 1994). Among other influences, it pro-
motes hematopoietic progenitor cell survival and acts
synergistically with GM-CSF, G-CSF, IL-3, and Epo to
enhance in vitro colony formation by early progenitors
of various lineages (McNiece et al., 1991). Figure 5C
illustrates that p62dok was rapidly tyrosine-phosphory-
lated after stimulation of Mo7 cells with c-Kit ligand.
This result indicates that tyrosine phosphorylation of
p62dok is a rapid biochemical event occuring shortly after
a receptor tyrosine kinase is activated.
Thereupon, we investigated whether or not p62dok was
Figure 4. Peptide Competition Analysis with p62dok Antibodies the tyrosine-phosphorylated p62 we previously identi-
(A) Proteins precipitated from lysates of Mo7/p210 cells by anti- fied in lysates of primary chronic-phase CML progenitor
p62dok antibodies were separated by SDS±PAGE and transferred cells (Wisniewski et al., 1994). Figure 5D illustrates that
to nitrocellulose. The membrane was probed with antibodies to
anti-p62dok antibodies immunoprecipitated a pTyr-con-phosphotyrosine. Prior to immunoprecipitation, lysates were incu-
taining protein that comigrated during SDS±PAGE withbated for 15 min with the indicated peptide: (2), no peptide; (1),
the tyrosine-phosphorylated p62 that coimmunoprecipi-antigenic peptide; and (unr.), unrelated peptide. Arrows indicate
p62dok doublet. (Ig) indicates immunoglobulin. tated with GAP antibodies from lysates of CML progeni-
(B) Proteins precipitated from lysates of Mo7/p210 cells by anti- tor cells (Figure 5D, upper panel, lanes 2 and 3). In
GAP antibodies were separated by SDS±PAGE and transferred to addition, GAP could be observed in anti-p62dok immuno-
nitrocellulose. The membrane was then probed with p62dok antibod-
precipitates (Figure 5D, lower panel, lane 3). Further-ies in the presence or absence of the indicated peptide: (2), no
more, p62dok antibodies quantitatively depleted the ly-peptide; (1), antigenic peptide; and (unr.), unrelated peptide. Arrows
sates of a pTyr-containing p62 to make it likely thatindicate p62dok doublet. (mAb) indicates cross-reacting monoclonal
antibody. p62dok was the constitutively tyrosine-phosphorylated
protein migrating at 62 kDa in CML progenitor cells (Fig-
ure 5D, lower panel, lane 7). We conclude that p62dok isthat the antibodies recognized a constitutively tyrosine-
the 62 kDa GAP-associating protein previously reportedphosphorylated, GAP-associated p62 from Mo7/p210
to be constitutively tyrosine-phosphorylated in the he-cells.
matopoietic progenitor-cell population of CML patients.
Analysis of p62dok
At present, the only biochemical difference between
DiscussionMo7 p62dok and Mo7/p210 p62dok that we have detected
is the presence of phosphotyrosine residues in the latter
Given the important signaling role that tyrosine kinasespopulation (Figure 5A). Both populations contained
play in hematopoietic growth control, it is not surprisingphosphoserine, although whether identical serine resi-
that the sudden appearance of a novel tyrosine kinasedues are phosphorylated is unknown. Moreover, a com-
activity (e.g., p210bcr-abl) within a single,primitive progeni-bined immunoprecipitation/immunoblot assay indicated
tor cell would perturb the intracellular signaling cas-that Mo7 p62dok migrated by SDS±PAGE as a singletof 61
cades that ensure orderly hematopoiesis (Bolen et al.,kDa (Figure 5B, lane 11), whereas it shifted completely to
1992). The two fused portions of p210bcr-abl are each de-two slower migrating forms of 62 and 64 kDa in Mo7/
rived from molecules that themselves contain some ofp210 cells (Figure 5B, lane 12). This quantitative shift
the modular features common to signaling proteins (Co-suggests that the entire population of p62dok within the
hen et al., 1995). In addition, Bcr-Abl is a large moleculecell is altered by the presence of p210bcr-abl. Both forms
that is extensively tyrosine-phosphorylated, providingof p62dok in p210bcr-abl-containing cells were tyrosine-
numerous potential docking sites for SH2 domain±phosphorylated, and both forms could be detected in
containing proteins. Thus, this activity could interactanti-GAP immunoprecipitates (Figure 5B, lanes 2 and 8)
with various components of preexisting signaling net-and in anti-pTyr immunoprecipitates (Figure 5B, lanes
works within a primitive stem cell (see Pawson, 1995).4 and 10). However, preliminary data indicates that only
Current evidence suggests that p62dok is a substrate ofa small proportion of total tyrosine-phosphorylated
the constitutive tyrosine kinase activity of p210bcr-abl andp62dok complexes with GAP (Figure 5B, compare lane 8
that its abnormal modification within Ph1 primitive he-with lane 12). The faster-migrating, nontyrosine-phos-
matopoietic progenitors plays a role in the complexphorylated form of p62dok in Mo7 cells was not found
associated with GAP (Figure 5B, lanes 1 and 7). physiological disorder manifested in the chronic phase
GAP-Associated p62 Protein
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Figure 5. Tyrosine Phosphorylation of p62dok
(A) Tyrosine phosphorylation of p62dok in cells
containing p210bcr-abl. Lysates from 32P-la-
beled Mo7 or Mo7/p210 cells were subjected
to immunoprecipitation with anti-p62dok anti-
bodies, and precipitated proteins were ana-
lyzed by SDS±PAGE (left panel). Labeled
p62dok (indicated by bracket) was excised
from the gel, hydrolyzed, and subjected to
2D thin-layer chromatography (right panels).
(pS) indicates phosphoserine; (pY) indicates
phosphotyrosine.
(B) Only tyrosine-phosphorylated p62dok as-
sociates with GAP. Immunoprecipitations
from either Mo7 or Mo7/p210 cells were con-
ducted with the indicated antibodies, and im-
mune complexes were analyzed by Western
blotting with the indicated antibodies. Brack-
ets indicate p62dok.
(C) p62dok is tyrosine-phosphorylated upon
c-Kit stimulation. Lysates from untreated (09)
or c-Kit-stimulated (59) Mo7 cells were used
for immunoprecipitation with anti-p62dok anti-
bodies, and immune complexes were subse-
quently separated by SDS±PAGE, transferred
to nitrocellulose, and analyzed by immu-
noblotting with the indicated antibody: anti-
pTyr antibody (upper panel) or anti-p62dok an-
tibody (lower panel).
(D) p62dok is constitutively tyrosine-phosphor-
ylated in primary human chronic-phase CML
progenitor cells. Lysates of primitive blasts
were subjected to immunoprecipitation with
the indicated antibody. Anti-cdc2 antibodies
and normal serum served as negative con-
trols. Western blot was performed with anti-
pTyr antibodies (upper panel), following
which the blot was stripped and reprobed
with antibodies to GAP (lower panel). One-
eighth of the original cell lysate or one-eighth
of the supernatant from each immunoprecipi-
tation was also analyzed.
of CML. Constitutive tyrosine phosphorylation of p62 domain of the polypeptide. The majority of tyrosines
within p62dok are located in the C-terminal half of theis detected in all primary chronic-phase CML primitive
blasts observed to date (Wisniewski et al., 1996). molecule, and we speculate that they are available as
targets for the activity of neighboring tyrosine kinasesAs a potential signaling molecule, p62dok has several
noteworthy features. It contains a putative PH domain at (e.g., p210bcr-abl itself). It is possible that these tyrosines,
when phosphorylated, serve as docking sites for pro-its extreme amino terminus, comprising residues 3±119
(Musacchio et al., 1993). A variety of proteins involved teins that contain SH2 domains. In addition to the
C-terminal tyrosines, p62dok contains ten PXXP motifs.in signaling and/or cytoskeletal organization contain PH
domains, among them GAP. A proposed function of the Because PXXP is the core conserved sequence of pro-
line-rich regions that are recognized by SH3 domains,PH domain is to mediate protein±protein interactions
(Pawson, 1996). Additionally, it is thought that these it is possible that p62dok can interact with signaling mole-
cules containing SH3 domains (Yu et al., 1994).conserved structural domains mediate interactions with
cellular membranes, possibly by binding to different ino- p62dok binds in vitro to the N terminus of GAP, sug-
gesting that tyrosine-phosphorylated p62dok interacts insitol phosphate components of the lipid bilayer. For ex-
ample, the PH domain of PLCd1 binds specifically and vivo with the SH2 domains of GAP. Originally, GAP was
identified based on its abililty to increase the intrinsicwith high affinity to PtdIns2 (Lemmon et al., 1996). Thus,
the function of the N-terminal region of p62dok might be GTPase activity of ras (Trahey and McCormick, 1987).
Its catalytic domain is located in the C-terminal half ofto serve as a modular binding domain, either localizing
the molecule to the cell surface or directing its interac- the molecule. In recent years, evidence has accumu-
lated that the N terminus of GAP plays a functional roletion with a variety of proteins. If the function of the PH
domain of p62dok is to bind other proteins or components in intracellular signaling, separate and distinct from the
C terminus (see Valius et al., 1995). For example, overex-of the membrane, then the C-terminal portion of the
molecule would likely be positioned to interact with a pression of the N-terminal region of GAP in Rat-2 cells
resulted in disruption of the actin cytoskeleton and focalvariety of proteins and/or small molecules within the
cytosol. Therefore, it might contain a critical functional contacts, as well as decreased fibronectin binding and
Cell
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maintained in RPMI (GIBCO) 1 10% Fetal Clone III (Hyclone) at 378Ccell adhesion (McGlade et al., 1993). Therefore, it is pos-
and 5% CO2. The Mo7 growth media contained 10 ng/ml recombi-sible that constitutive p62dok association with GAP might
nant GM-CSF (kindly provided by Genetics Institute, Boston, MA).deregulate a signaling network involving the N terminus
For immunoprecipitations, cells were washed twice in PBS con-
of GAP. Currently, it is unclear whether the association taining 1 mM Na3VO4 and 100 mM phenylarsine oxide (PAO) and
of p62dok with GAP is due solely to a direct interaction lysed. Lysis buffer (LB) was 50 mM Tris±HCl (pH 7.6), 150 mM NaCl,
between a phosphotyrosine of the former and the SH2 5 mM EDTA, 1 mM EGTA, 1% Triton X-100, 0.5 mg/ml leupeptin,
50 mg/ml soybean trypsin inhibitor, 0.1 mg/ml aprotinin, 100 mg/mlregion(s) of the latter. In view of the PXXP motifs of
PMSF, 1 mM Na3VO4, and 100 mM PAO. Prior to precipitations, cellp62dok, it is possible that the SH3 domain of GAP stabi-
lysates were clarified by centrifugation at 14,000 rpm at 48C. Lysateslizes the association of the two molecules.
were precleared by 15 min rotation at 48C with Protein A±SepharoseAlthough at present the biological function of p62dok
(Pierce). Following addition of antibody, immune complexes were
is unknown, several lines of evidence suggest that it allowed to form during a 90 min rotation at 48C. After Protein
plays a role in distinct signal transduction networks, A±Sepharose was added, rotation at 48C was continued for 1 hr.
most likely as a component of a signaling cascade initi- Then, the beads were washed five times in buffer containing 20 mM
Tris±HCl (pH 7.6), 150 mM NaCl, 1 mM EDTA, 0.1% Triton X-100,ated by receptor or membrane-associated tyrosine
100 mg/ml PMSF, and 1 mM Na3VO4. SDS±PAGE and Western trans-kinases. The rapid tyrosine phosphorylation of the GAP-
fer were done according to standard protocols (Harlow and Lane,associated p62 in Rat-1 fibroblasts upon EGF stimula-
1988). The following antibodies were used for the precipitations:tion and in Rat-2 fibroblasts upon PDGF stimulation
anti-GAP mAb B4F8 (Santacruz),anti-pTyr mAb PY20 (ICN), anti-p68
has been reported (Ellis et al., 1990). Using a different polyclonal antibody SC-108 (Santacruz), and anti-p62dok polyclonal
system, Filvaroff et al. (1992) demonstrated the tyrosine antibody (see below). The following antibodies were used for immu-
phosphorylation of a GAP-associated p62 in primary noblotting: anti-pTyr polyclonal antibody B5 (Kozma et al., 1991),
anti-pTyr mAb 4G10 (UBI), anti-GAP polyclonal antibody RH6±2A,mouse keratinocytes as one of the initial events in cal-
and anti-p62dok polyclonal antibody.cium-induced terminal differentiation. Finally, it has
To radiolabel proteins, cells were incubated in phosphate-freebeen demonstrated that c-Kit ligand induces the rapid
media containing 10% dialyzed fetal calf serum (GIBCO) and 1 mCi/tyrosine phosphorylation of a p62, most likely the GAP-
ml 32P-orthophosphate (ICN). Following a 2 hr labeling period, cells
associated p62, in primitive hematopoietic progenitors were washed twice and immunoprecipitations were conducted as
(Wisniewski et al., 1996). In this report, we demonstrate described above. Phosphoamino acid analysis of p62dok was con-
directly that p62dok is rapidly tyrosine-phosphorylated ducted as described (van der Geer et al., 1993), as was 2D gel
electrophoresis (Garrels, 1983).upon activation of the c-Kit receptor tyrosine kinase,
Peptide competition experiments were conducted by incubatingsuggesting that it lies on a signaling pathway down-
antigenic peptide or unrelated peptide either with cell lysate priorstream of the c-Kit receptor.
to immunoprecipitation (Figure 3A) or with nitrocellulose prior toIn light of the constitutive tyrosine phosphorylation of
Western blotting (Figure 3B).
p62dok in hematopoietic progenitors containing p210bcr-abl, Hematopoietic progenitor cells from CML patients in the chronic
it is provocative that some of the biological effects of phase were isolated and processed for immunoprecipitation exactly
both p210bcr-abl and c-Kit ligand appear to be similar, and as described (Wisniewski et al., 1996).
these effects are manifested in a relatively mature stem-
cell population at the time of lineage commitment rather Purification of p62dok
Fifty liters of Mo7/p210 cells were grown to a density of 2 3 106/mlthan at the level of a self-renewing stem cell (Strife et
in RPMI containing 20 mM HEPES (GIBCO) and 5% Fetal Clone IIIal., 1993). Furthermore, because tyrosine phosphoryla-
(Hyclone) and treated for 10 min at 378C with 100 mM PAO in growthtion of p62dok was observed in chronic-phase progenitor
media. The cells were washed as above and lysed in LB containingcells from all CML patients tested (Wisniewski et al.,
50 mM NaCl. The lysate was adjusted to 3 M urea by the addition
1994, 1996), it is possible that the aberrant or untimely of buffer containing 6 M urea, following which it was adjusted to
tyrosine phosphorylation of p62dok is a key step in the pH 8.2 and batch-adsorbed to Q-Sepharose HP (Pharmacia). Bound
development of the chronic phase of CML. proteins were step-eluted with buffer containing 225 mM NaCl. The
eluate was adjusted to 50 mM acetate (pH 4.6) by the addition of 2Numerous investigators working with a variety of
vol of 75 mM acetic acid, 5 mM EDTA, and 3 M urea. Then, proteinstransformed cell lines have observed the tyrosine phos-
were batch-adsorbed to SP ToyoPearl (TosoHaas) and step-elutedphorylation of a p62 and its association with GAP (Ellis
with buffer containing 300 mM NaCl. Total protein was then precipi-
et al., 1990; Moran et al., 1991). Murine p62dok has been tated with cold acetone. The precipitate was resuspended in 8 M
identified and demonstrated to be directly associated urea; dialyzed against 50 mM Tris±HCl (pH 7.6), 150 mM NaCl, 5
with the v-Abl activated tyrosine kinase (see accompa- mM EDTA, 0.1% Triton X-100, and 0.5 mM Na3VO4; and loaded onto
nying paper, Yamanashi and Baltimore, 1997 [this issue an anti-pTyr antibody column, 4G10-Sepharose (UBI). The column
was washed with load buffer and distilled water, and bound proteinsof Cell]). In addition, the extent of tyrosine phosphoryla-
were eluted by the additon of 4% acetic acid. Following removal oftion of p62 has been shown to correlate with the trans-
the solvent by lyophilization, the eluted material was resolved by 2Dforming capabilities of a number of different oncogenes,
gel electrophoresis. The peptide sequence of p62dok was obtained asincluding v-src, v-abl, and v-fps (Ellis et al., 1990; Lugo
described (Wang et al., 1996).
et al., 1990). The widespread correlation betweenconsti-
tutive tyrosine phosphorylation of p62dok and the trans-
cDNA Cloning
formed phenotype suggests that p62dok plays an impor- Total RNA, extracted from Mo7/p210 cells with RNAzol (Tel-Test,
tant role in mitogenic signaling and that the aberrant Inc.), was used to make random primed cDNA for the RT±PCR.
phosphorylation of p62dok might contribute to the pro- Reverse transcription was carried out at 508C with Superscript II
gression of different human diseases. (GIBCO BRL). Three rounds of nested PCR were conducted with
degenerate primers designed based on the amino acid sequence
of peptides WAVLYPASPHGVARLEFFDHK and PLYWDLYEHAQQQExperimental Procedures
LLK. The resulting PCR product was radiolabeled and used as a
probe to screen an oligo(dT)-primed human teratocarcinoma cDNAImmunoprecipitation and Western Blot Analysis
library (Skowronski et al., 1988). Hybridization was performed asThe Mo7 cell line and a derivative of Mo7 that expresses p210bcr-abl,
Mo7/p210 (kindly provided by Dr. Brian Druker, Portland, OR), were described (Sambrook et al., 1989). Positive clones were isolated,
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phage DNA was purified, cDNA inserts were excised by restriction R. Wu, L. Grossman, and K. Moldave, eds. (San Diego, California:
Academic Press), pp. 411±423.enzyme digest, and the longest insert was cloned into a plasmid
vector (pBluescript, SK2) for DNA sequencing, all using standard Groffen, J., Morris, C., and Heisterkamp, N. (1991). The Philadelphia
methodologies (Sambrook et al., 1989). For Northern analysis, blots chromosome translocation. In Chronic Myelogenous LeukemiaÐ
of poly(A)1 RNA from different human tissues (Clontech) were Molecular Approaches to Research and Therapy, A.B. Deisseroth
probed with a radiolabeled 1526 bp fragment of Dok cDNA obtained and R.B. Arlinghaus, eds. (New York: Marcel Dekker), pp. 181±207.
by PCR, according to the instructions of the manufacturer.
Harlow, E., and Lane, D. (1988). Antibodies: A Laboratory Manual
(Cold Spring Harbor, New York: Cold Spring Harbor Laboratory
Anti-p62dok Antibodies Press).
A peptide with a C-terminal cysteine was synthesized (PQGPAFPEP
Konopka, J., Watanabe, S.M., and Witte, O.N. (1984). An alteration ofGTATGSC; BioSynthesis, Inc.), conjugated to maleimide-activated
the human c-Abl protein in K562 leukemia cells unmasks associatedKLH (Pierce), and used to immunize rabbits (Hazelton). Anti-peptide
tyrosine kinase activity. Cell 37, 1035±1042.antibodies were purified by affinity chromatography over a peptide
column (Sulfo-link Coupling Gel, Pierce). Kozma, L.M., Rossomando, A.J., and Weber, M.J. (1991). Compari-
son of three methods for detecting tyrosine phosphorylated pro-
teins. Methods Enzymol. 201, 28±43.Stimulation with c-Kit Ligand
Exponentially growing Mo7 cells (107/IP) were washed free of growth Lemmon, M.A., Ferguson, K.M., and Schlessinger, J. (1996). PH
factor and incubated for 16 hr at 378C in IMDM (GIBCO) containing domains: diverse sequences with a common fold recruit signaling
1% fetal calf serum (GIBCO). Cells were then pelleted by centrifuga- molecules to the cell surface. Cell 85, 621±624.
tion, resuspended in IMDM 1 1% serum, and exposed to c-Kit
Lock, P., Fumagalli, S., Polakis, P., McCormick, F., and Courtneidge,
ligand (100 ng/ml) for 5 minutes at 378C. Cells were then washed
S.A. (1996). The human p62 cDNA encodes Sam68 and not the
once with PBS and processed for immunoprecipation and Western
rasGAP-associated p62 protein. Cell 84, 23±24.
blot analysis exactly as described (Wisniewski et al., 1996). Human
Lugo, T.G., Pendergast, A.M., Muller, A.J., and Witte, O.N. (1990).recombinant c-Kit ligand was from Immunex Corp., Seattle.
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